Biodesix, Inc. Share Price & Technical Analysis
BDSX · $14.93 (0.00%)
Healthcare / Diagnostics & Research
$14.93
0.00%
Biodesix, Inc. operates as a diagnostic solutions company. The company offers blood-based lung tests, including Nodify XL2 and Nodify CDT tests markets as Nodify Lung Nodule Risk Assessment testing to assess the risk of lung cancer and help in identifying the appropriate treatment pathway and help physicians in reclassifying risk of malignancy in patients with suspicious lung nodules. It also prov…
Price chart
Seasonality
May has 2 positive and 3 negative years (last 5 years shown)
37% return in May, -14% avg return in past 3 year May month.
117% return in 2026, -49% avg return in past 3 years.
Swipe sideways to see all months →
| Jan | Feb | Mar | Apr | May | Jun | Jul | Aug | Sep | Oct | Nov | Dec | Yr | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 26 | 50% | 55% | 0% | -24% | 37% | – | – | – | – | – | – | – | 117% |
| 25 | -32% | -20% | -25% | -15% | -44% | -7% | 25% | 23% | -11% | -9% | 22% | -16% | -109% |
| 24 | 13% | -25% | -25% | -14% | 16% | 6% | 8% | 17% | -10% | -5% | -14% | 6% | -27% |
| 23 | 6% | -16% | -10% | -6% | -15% | -12% | -7% | 29% | 3% | -11% | 3% | 23% | -13% |
| 22 | -24% | -40% | -27% | -5% | -9% | 11% | 25% | -14% | -32% | -20% | 91% | 43% | -1% |
Monthly return % by calendar month · historical pattern, not a forecast
Neutral · Strong · Uptrend
Biodesix, Inc. operates as a diagnostic solutions company. The company offers blood-based lung tests, including Nodify XL2 and Nodify CDT tests markets as Nodify Lung Nodule Risk Assessment testing to assess the risk of lung cancer and help in identifying the appropriate treatment pathway and help physicians in reclassifying risk of malignancy in patients with suspicious lung nodules. It also provides GeneStrat ddPCR, GeneStrat NGS, and VeriStrat tests markets as part of IQLung testing strategy, which are used in the diagnosis of lung cancer to measure the presence of mutations in the tumor and the state of the patient's immune system to guide treatment decisions. In addition, the company provides diagnostic solutions, including translational research, initial biomarker discovery, assay design, development and validation, testing of clinical trial samples, regulatory, reimbursement, commercialization, and logistical support services for biopharmaceutical, life sciences, and diagnostic companies. Further, it operates laboratories. The company was formerly known as Elston Technologies, Inc. and as changed to Biodesix, Inc. in 2006. Biodesix, Inc. was incorporated in 2005 and is headquartered in Louisville, Colorado.
Full AI Q&A, portfolio tracking, and live alerts in the app.
Key metrics
Market cap
$156.48M
P/E ratio
—
52W high
$20.21
52W low
$5.00
Volume
10,270
Beta
0.42
Related stocks in Healthcare
Merck & Co Inc Cedear (5…
₹32,900
Abbott Laboratories Cede…
₹30,500
Eli Lilly And Company Ce…
₹25,540
Unitedhealth Group Inc C…
₹17,200
₹6,600
Frequently asked questions
- What is Biodesix, Inc. share price today?
- Biodesix, Inc. (BDSX) last traded around $14.93 on StockPro. Prices refresh every few minutes during market hours.
- What technical signals does BDSX have?
- StockPro monitors breakouts, volume spikes, EMA reversals, and momentum for BDSX. Download the app for real-time alerts.
- How can I analyze Biodesix, Inc. stock?
- Use the price chart, seasonality heatmap, key metrics, and AI insight on this page. For portfolio tracking and push alerts, download StockPro on Android or iOS.